• transplant emblem
  • imageBanner

Why choose UNC for potential transplant patients?

Patients at UNC benefit from our strong emphasis on collaboration between referring physicians, and clinical and research teams throughout the hospital. That collaboration has led to importance advances in immunosuppressive medicines for transplant patients, along with the creation of a special team dedicated to preventing infections in transplant patients.

UNC also leads the way in furthering research on leading-edge techniques that give more patients access to life-saving organ transplants. Our kidney transplant program has had proven success with the use of Expanded Criteria Donor (ECD) and Donation after Cardiac Death (DCD) to make more kidneys available to critically ill patients.

In addition, UNC is one of only a few programs in the world conducting research in the field of ex-vivo lung perfusion. This highly specialized technique allows the medical team to take lungs that might traditionally be considered unsuitable for transplant, and repair them outside the donor before transplanting them into the patient, an especially important step forward because of the damage that often occurs to otherwise-healthy lungs during end-of-life treatment.